These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20564128)

  • 1. Understanding the variation in treatment intensity among patients with early stage bladder cancer.
    Hollingsworth JM; Zhang Y; Krein SL; Ye Z; Hollenbeck BK
    Cancer; 2010 Aug; 116(15):3587-94. PubMed ID: 20564128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding bladder cancer death: tumor biology versus physician practice.
    Morris DS; Weizer AZ; Ye Z; Dunn RL; Montie JE; Hollenbeck BK
    Cancer; 2009 Mar; 115(5):1011-20. PubMed ID: 19152434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional differences in early stage bladder cancer care and outcomes.
    Skolarus TA; Ye Z; Zhang S; Hollenbeck BK
    Urology; 2010 Aug; 76(2):391-6. PubMed ID: 20394976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population.
    Schrag D; Mitra N; Xu F; Rabbani F; Bach PB; Herr H; Begg CB
    Urology; 2005 Jun; 65(6):1118-25. PubMed ID: 15922428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying better practices for early-stage bladder cancer.
    Hollingsworth JM; Zhang YS; Miller DC; Skolarus TA; Wood DP; Lee CT; Montie JE; Hollenbeck BK
    Med Care; 2011 Dec; 49(12):1112-7. PubMed ID: 21979371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient time costs associated with cancer care.
    Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
    J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
    Konety BR; Joslyn SA
    J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provider treatment intensity and outcomes for patients with early-stage bladder cancer.
    Hollenbeck BK; Ye Z; Dunn RL; Montie JE; Birkmeyer JD
    J Natl Cancer Inst; 2009 Apr; 101(8):571-80. PubMed ID: 19351919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
    Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of malpractice caps on use and outcomes of radical cystectomy for bladder cancer: data from the surveillance, epidemiology, and end results program.
    Konety BR; Dhawan V; Allareddy V; Joslyn SA
    J Urol; 2005 Jun; 173(6):2085-9. PubMed ID: 15879848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare.
    Ramsey SD; Howlader N; Etzioni RD; Donato B
    J Clin Oncol; 2004 Dec; 22(24):4971-8. PubMed ID: 15611512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical model of cost of bladder cancer in the elderly.
    Cooksley CD; Avritscher EB; Grossman HB; Sabichi AL; Dinney CP; Pettaway C; Elting LS
    Urology; 2008 Mar; 71(3):519-25. PubMed ID: 18342201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older.
    Hollenbeck BK; Miller DC; Taub D; Dunn RL; Underwood W; Montie JE; Wei JT
    Urology; 2004 Aug; 64(2):292-7. PubMed ID: 15302481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base.
    Konety BR; Joslyn SA; O'Donnell MA
    J Urol; 2003 Mar; 169(3):946-50. PubMed ID: 12576819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of changes in Medicare reimbursement on the practice of office and hospital-based endoscopic surgery for bladder cancer.
    Hemani ML; Makarov DV; Huang WC; Taneja SS
    Cancer; 2010 Mar; 116(5):1264-71. PubMed ID: 20143327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discharge practice patterns following cystectomy for bladder cancer: evidence for the shifting of the burden of care.
    Taub DA; Dunn RL; Miller DC; Wei JT; Hollenbeck BK
    J Urol; 2006 Dec; 176(6 Pt 1):2612-7; discussion 2617-8. PubMed ID: 17085172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal management of high-risk T1G3 bladder cancer: a decision analysis.
    Kulkarni GS; Finelli A; Fleshner NE; Jewett MA; Lopushinsky SR; Alibhai SM
    PLoS Med; 2007 Sep; 4(9):e284. PubMed ID: 17896857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Care of long-term cancer survivors: physicians seen by Medicare enrollees surviving longer than 5 years.
    Pollack LA; Adamache W; Ryerson AB; Eheman CR; Richardson LC
    Cancer; 2009 Nov; 115(22):5284-95. PubMed ID: 19685532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.